Neuronetics (STIM) Other Non-Current Liabilities (2017 - 2026)
Neuronetics (STIM) posted quarterly Other Non-Current Liabilities of $71000.0 for Q1 2026, down 96.25% quarter-over-quarter from $1.9 million in Q2 2018.
Neuronetics (STIM) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Other Non-Current Liabilities for 3 consecutive years, with $71000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $71000.0; the TTM figure through Mar 2026 stood at $71000.0 (changed N/A YoY), while the FY2017 annual figure was $478000.0, changed N/A from the prior year.
- Other Non-Current Liabilities fell to $71000.0 in Q1 2026 per STIM's latest filing, from $1.9 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $71000.0 in Q1 2026 and bottomed at $71000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Neuronetics | 221.22 Mn | 201.78 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 142,000.00 |
| Mar 31, 2026 | 71,000.00 |
| Jun 30, 2018 | 1.89 Mn |
| Dec 31, 2017 | 478,000.00 |